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would affect PCV2 transmission to a susceptible host such as cattle. The pig population of farm 1
had recurrent PMWS cases among weaners. The 34 cattle in proximity to the PMWS-affected pigs
included 14 cattle (41%) that carried a PCV2 load of on average 2.5 x 105 virus genomes per ml blood.
Among these was a 7 years old cow with chronic mastitis that was infected with the highest PCV2 load
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Abstract
Porcine circovirus type 2 (PCV2) has a major economic impact on pig production. Vaccination against the virus
appears to keep PCV2 disease (PCVD) manifestations in check. Nevertheless, PCV2 has not been eliminated.
Several reports indicate that cattle also seem to be susceptible to PCV2 infection. In this study, we detected
increased PCV2 cross-species transmission and suggest a strategy for identifying hidden PCV2 infection in cattle.
We compared a postweaning multisystemic wasting syndrome (PMWS) distressed-farm with a sub clinically-infected
farm and investigated how differences in virus concentration would affect PCV2 transmission to a susceptible host
such as cattle. The pig population of farm 1 had recurrent PMWS cases among weaners. The 34 cattle in proximity
to the PMWS-affected pigs included 14 cattle (41%) that carried a PCV2 load of on average 2.5 x 105 virus
genomes per ml blood. Among these was a 7 years old cow with chronic mastitis that was infected with the highest
PCV2 load of 1.3 x 106 virus genomes per ml blood. These numbers contrasted with farm 2 that housed PCV2-
subclinically infected pigs in proximity to 31 cattle of which six (19%) were infected with an average of 1.7 x 105
virus genome per ml blood. No PCV2-specific humoral response was measured in these cattle. Additionally, we
encountered the problem of how to measure PCV2 latent/persistent infections. In pigs, after a one-shot vaccination,
we have previously observed a direct anti-PCV2 IgG response instead of the expected IgM response. This indicated
that the pig immune system was already primed with PCV2. We therefore hypothesized that cattle may also be
PCV2-primed. Although the cattle’s humoral immune system hardly responded to vaccination, we detected PCV2-
specific IgG antibody in one cow after the first vaccination shot. This, taken together with the PCV2 transmission rate
in hybrid farms indicated sporadic infections in the cattle population. Thus, it can be concluded that PCV2 infections
were not well established in cattle in comparison to the situation in swine.
Keywords: Porcine circovirus type 2 diseases; Pig; Cattle;
Vaccination; Cross-species transmission
Introduction
Porcine circovirus type 2 (PCV2) is the main etiological agent for
porcine circovirus diseases (PCVD) including post weaning
multisystemic wasting syndrome (PMWS) [1,2,3]. The virus’s
associations with recurrent pandemics in pigs are seen as a real threat
to pig production. Paradoxically, PCV2 is endemic in the pig
population and can be found both in healthy as well as in diseased pigs
[3,4]. The virus latent/ persistent presence [3,5] is a constant threat for
the host immune system. PCV2 uses a measurable amount of host
metabolism reflected by a reduction in pig’s daily weight gain [3,6].
Detection of anti-PCV2 IgG antibodies is not a reliable indicator of
individual infection status [7]. Furthermore, in disease the anti-PCV2
IgG antibodies are often absent [8]. This, and the lack of a meaningful
T-cell response against the PCV2 capsid protein [9] now makes more
sense in the light of our proposed pathogenicity mechanism [3]. We
have shown that pig foetuses already carry the virus in the thymus
even before immune competence, which is central to the virus complex
pathogenicity [5].
A study indicated the presence of anti-PCV antibodies in a broad
range of sera including mouse and human [10]. However, more specific
assays demonstrated that PCV2-specific antibody were not that
common after all [11,12]. More than a decade after the initial report
[13], another report surfaced that described a high similarity between
PCV2 and virus DNA from cattle [14]. Other authors confirmed the
presence of PCV2 DNA in hosts unrelated to pig [15] and even
indicated that the virus could potentially cause similar syndromes in
cattle like the ones seen in pigs [16]. Thus, it was important to question
the susceptibility of cattle to PCV2 infections [17]. These research
scientists’ experiments indicated that cattle are generally susceptible to
PCV2 infections [17]. However, in these experiments it was not
possible to reliably identify the infected cattle and show that PCV2
singly led to disease in cattle [17]. This is reminiscent of the findings in
swine that show in addition to double PCV2 genotype group infections
[18] several other factors might separately or combined be important
for disease development [3,19,20].
We think the difficulties in interpretation of the pathogenicity
mechanism also originated from the nature of the latent virus infection
early in pig’s ontogeny [5] with sporadic, recurrent viremia [3,5]. For
the diagnosis of disease, the viral load in the lymphatic system and
viremia are an indication of disease progress in the animal [3,21,22].
Furthermore, we believe that the virus capsid load in the thymus is
central as a diagnostic parameter to define disease [3]. The levels of
virus concentrations seem to be dependent on the genetics of the host
[3,23,24,25], the viral genotype group member/s [18] and/or another
cofactor/s [1,2,20].
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It is thought that PCV2 was transferred from wild boar to the
domestic pig less than one hundred years ago [26]. It then took more
than half a century and several pig generations before the first case of
PMWS diseased in 1991 [27]. The current situation in cattle seems to
be early in PCV2 infection evolution and hence interesting questions
are raised about host infections by these viruses. We were primarily
interested whether a higher virus pressure (as found in the
environment of PMWS-affected pigs) versus that on a sub clinically
infected farm might be determined in a susceptible host like cattle.
Material and Methods
Ethics statement
The animal experiments and protocols were approved by the
Animal Welfare Committee of the Canton Zurich (authorization no.
177/2011). Handling of and experiments with cattle were carried out in
accordance with EU standards and the Swiss Animal Welfare law
(Tierschutzgesetz SR455).
Two farms with both pig and cattle cohort
We selected two farms that contained a cohort of pigs in close
proximity to a cohort of cattle: on farm 1, 30 dams (producing about
720 weaners per year) were kept together with 34 cattle in the same
housing complex separated by a wall. The pig population on the farm
was diagnosed with PMWS and no other pathogens were detected
[28]. Weaned pigs from 30 sows persistently developed PMWS over a
period of several months. Morbidity of up to 30% and a lethality of
about 75% was estimated among the weaned pigs. On farm 2, 100
dams (producing about 2600 weaners per year) were housed separated
about 30 m from the cattle housing. Routine diagnosis of the blood
from pigs and weaners indicated PCV2 infections. However, no clinical
signs of disease (no porcine circovirus disease history) and an absence
of major respiratory and intestinal pathogens that may affect piglets
were observed. The study ended shortly before two pigs developed
PMWS [28]. On both farms, the workers changed clothes when
moving from one shed to the other.
Cattle vaccination against PCV2
Eight cattle, aged 2-6 years, were used for the vaccination trial. Four
cattle were vaccinated twice with an interval of three weeks with 2 ml
of Circovac® (2 ml ≥ 2.1 log10 PCV2 antigen unit, 0.2 mg thiomersal
and 500 mg paraffin as adjuvant) from Merial Inc. (Lyon, France) and
the other four cattle were injected using the same vaccination regime
with adjuvant only as controls. Vaccination or adjuvant was
subcutaneously injected. Blood samples were taken before the first
vaccination, 3 weeks after the first vaccination and 3 weeks after the
second vaccination.
PCV2 detection in whole blood by PCR
Cattle blood was collected from the jugular vein and directly
transferred into EDTA coated tubes S-Monovette (Sarstedt, Sevelen,
Switzerland). We used an in-house sybr-green based real-time PCR as
described in Klausmann et al. [3]. We quantified ≥ 40 virus genome
copies per l blood as a positive PCV2 infection.
Anti-PCV2-IgG and-IgM ELISAs
We used the competitive ELISA, SERELISA® PCV2 Ab Mono
Blocking Systems of Symbiotic Corporation Europe SAS (Lyon,
France) and the assay of INGEZIM CIRCOVIRUS IgG/IgM® of
Ingenasa (Madrid, Spain) to detect PCV2-specific IgGs and PCV2-
specific IgMs in cattle sera, respectively. The assays were used
according to manuals instructions and Kurmann et al.[6].
Statistics
Data were analysed using Stata® (StataCorp., 2011; Stata Statistical
Software: Release 12.1; College Station, Texas, USA). Normal
distribution was tested using the Wilk-Shapiro test (Stata term <swilk
var>). Distributions were visualized using <glader var> or <graph box
var>. A two-sided unpaired t-test (<ttest vary, by (varx2)>) was used
for normally distributed data, the Kolmogorov-Smirnov test
(<ksmirnov vary, by(varx)>) as well as the Kruskal-Wallis rank test
(<kwallis vary, by(varx)>) was used for not normally distributed data,
whereby varx=farm variable, vary=ELISA value or the prevalence by
farm. Categorical data were analyzed using Chi2- or Fisher’s Exact-Test
(<tab2 varx1 varx2, cchi2 chi2 exact expected>). A p-value ≤ 0.05 was
considered significant.
Results
In our quest for proper real-time PCR controls, we noticed that
many pigs had variable concentration of PCV2 DNA in whole blood.
Consequently, we decided to establish a DNA standard for real-time
PCR unrelated to sera or blood from swine and chose cattle blood as a
control. To our surprise, we sporadically found PCV2 templates even
in the blood from cattle by PCR. We sequenced several amplificates
from cattle sera and blood. These sequences were of the PCV2b
genotype, namely PCV2-CH.
We selected two farms, each with a cohort of pigs with different
PCVD health statuses, in close proximity to a cohort of cattle. On both
farms PCV2-infected cattle were found. We sampled cattle blood for
the presence of PCV2 by real-time PCR: 20 (31%) out of 65 cattle on
the two farms contained on average 2.26 x 105 PCV2 genomes per ml.
The pig population from farm 1 was previously diagnosed with
PMWS, whereas farm 2 was sub clinically infected with PCV2. On
farm 1 (with PMWS manifestation), we found in close proximity to the
pigs, 14 cattle (41%) out of 34 carrying virus loads with an average of
2.5 x 105 virus genomes per ml blood (Figure 1). This cohort contained
a 7 years old cow, which was infected with the highest virus titter of 1.3
x 106 virus genomes per ml blood. This animal suffered from chronic
mastitis.
Furthermore, on farm 2, 6 (19%) out of 31 cattle with an average of
1.7 x 105 virus genomes per ml blood were found in the
neighbourhood of the sub clinically infected pig cohort (Figure 1). We
found by a one-sided Fischer analysis there was indeed a statistically
significant difference between the PCV2 infection grades of the cattle
cohorts in farm 1 compared to farm 2. The cattle carried significantly
more viruses when exposed to the higher PCV2 concentrations of the
PMWS pig cohort (Figure 1).
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Figure 1: Comparison of PCV2 cattle viremia on farm 1, which
housed cattle in the same complex as a PMWS pig cohort, and farm
2, with separate enclosed cattle shed in proximity to a PCV2-
subclinically infected pig cohort. The bars indicate PCV2-positive
infected cattle percentages. Curves indicate viremia mean
distribution.
Even though 20 cattle were PCV2-viremic, not one animal of the 65
had a meaningful humoral immune response against PCV2 in the
form of anti-PCV2 specific IgM or IgG antibodies measurable with the
aid of the ELISA assays. This led us to surmise whether cattle might
not generally be able to mount a humoral response to PCV2. We
decided to vaccinate cattle, which were not PCV2-viremic, with the
complete virus (Circovac®, Merial) or adjuvant control only. Three
weeks after the first immunization relative low titters of anti-PCV2 IgG
antibodies were measured (Table 1) when compared to PCV2-specific
IgG titters of vaccinated pigs. Only one cow, that also had the highest
response after the first immunization, developed a meaningful anti-
PCV2 IgG antibody titters when boosted with a second immunization
(Table 1).
Vaccinated
B0 B1 B2
R1 0 147 5078
R2 0 34 314
R3 0 37 557
R4 0 14 565
Controls
R5-R8 0 0 0
Table 1: PCV2 specific vaccinated cattle versus adjuvant injected
controls.
R1 to R8 were 8 cattle. B0 is the bleed before vaccination; B1 is the
bleed three weeks after first vaccination; B2 is the bleed three weeks
after boost. Numbers indicate mean PCV2 specific IgG concentrations
in ELISA units.
Discussion
Many studies including those from our group have found that pig
livestock is widely infected with PCV2 [2,5]. Moreover, scientific
reports also indicate that cattle are susceptible to PCV2 infections and
these viruses may even cause disease in cattle [16]. We therefore
analysed the prevalence of PCV2 infections in cattle. This undertaking
is not simple, as PCV2 infections are latent in pigs [3,5,29] and we
must therefore assume a similar infection characteristic may also be
found in other unrelated hosts. Thus, PCV2 might be present in the
host without being detected in the blood as viremia. PCV2-specific
antibody absence or specific antibody isotype presence may not
necessary reflect the infection/disease status of cattle. This discrepancy
in the pig has been reported by several groups including ourselves
[3,7,8,29]. In cattle, this phenomenon has not been previously
described, therefore we investigated the PCV2 status in two cohorts of
cattle. We observed 31% of cattle were PCV2-viremic, but none
showed an anti-PCV2 specific IgM or IgG humoral immune response.
As this is a study in progress, we cannot definitively ensure that the
assay used can detect a specific PCV2-IgM response from cattle.
However, the absence of specific antibody against PCV2 in cattle is not
easily explained by an unresponsiveness of the cattle immune response
as we found that vaccination against PCV2 provoked an anti-PCV2
IgG antibody humoral response against the virus. Nevertheless, it
appears when using the same vaccination protocols as used for pigs,
that the response to PCV2 in cattle is less efficient compared to the
pigs’ immune responses. This could reflect the natural historical
exposure of pigs to PCV2 [5] but would also support the notion that
PCV2 infection of cattle is in the early evolutionary phase of host
adaption.
Normally, after a single vaccination, anti-PCV2 IgM-specific
antibodies are indicative that the animals’ immune system had
encountered the antigen for the first time. The direct appearance of
anti-PCV2 IgG isotype antibody after virus-specific vaccination
suggests that these cattle were previously infected with PCV2. It is
interesting to note the potential of vaccination to reveal hidden latent
virus infections.
Further evidence of early evolutionary PCV2 host infection
adaption comes from the observation that close to PMWS-affected pig
farms, other animals carry PCV2 more often than animals in
proximity to the PCV2-subclinical infected pig cohort. As PMWS-
disease ridden pigs shed higher concentrations of PCV2 [21,22] this
would indicate that zoonosis of PCV2 is also virus concentration
dependent and additionally that the cattle are not saturated with PCV2
infections. However, we only found a statistically significant difference
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between the PCV2 infection grades of the cattle cohorts from the two
farms with a one-sided Fischer analysis. We think that bigger cattle
cohorts in proximity to the pigs would remove any ambiguity
regarding the conclusion.
We analysed blood of the three highest viremic cattle specific for
PCV2 DNA by PCR and sequenced the amplificates. These sequences
were not new, instead they belong to viruses of the PCV2b genotype,
namely the PCV2b-CH, which dominated the Swiss epizooty [28] and
seems to be present endemically throughout the pig population. As this
virus sequence is not novel or different from the dominant genotype
group member in pigs, this represents a real cross-species transmission
of PCV2, expanding into another unrelated species, namely cattle.
Out of these cattle cohorts, a 7 years old cow was infected with the
highest virus titter of 1.3 x 106 virus genomes per ml blood. The cow
suffered from chronic mastitis. Although we previously presented
evidence that PCV2-infected pigs have a deregulated T-cell response
[3], further investigations are needed to examine if the presence of
smaller concentrations of PCV2 virus titters may be sufficient to
induce disease in different host such as cattle. In this respect, chronic
mastitis in cattle might be an equivalent disease manifestation akin to
PCVDs in pigs. However, follow up studies need to confirm or
disprove this possibility.
Conclusion
PCV2b-CH is the dominant PCV2 infection in pigs, its transmission
to cattle is reported here for the first time. The higher concentration of
PCV2 from the pig PMWS farm supports cross-species transmission. It
is possible either that the PCV2 capsid protein is not that
immunogenic in cattle or both we may also be witnessing a real-time
occurrence of cross-species transmission from pig to cattle, occurring
even before the virus has adapted appropriately to the new host.
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